KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationAmortization - GoodwillCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares OutstandingShares Outstanding
Ratios

Bausch Health Companies (BHC) Accumulated Depreciation & Amortization (2016 - 2026)

Bausch Health Companies' Accumulated Depreciation & Amortization history spans 17 years, with the latest figure at $295.0 million for Q1 2026.

  • On a quarterly basis, Accumulated Depreciation & Amortization fell 3.28% to $295.0 million in Q1 2026 year-over-year; TTM through Mar 2026 was $295.0 million, a 3.28% decrease, with the full-year FY2025 number at $1.2 billion, down 4.66% from a year prior.
  • Accumulated Depreciation & Amortization hit $295.0 million in Q1 2026 for Bausch Health Companies, down from $1.2 billion in the prior quarter.
  • Over the last five years, Accumulated Depreciation & Amortization for BHC hit a ceiling of $1.9 billion in Q4 2022 and a floor of $295.0 million in Q1 2026.
  • Historically, Accumulated Depreciation & Amortization has averaged $1.0 billion across 5 years, with a median of $1.2 billion in 2023.
  • Biggest five-year swings in Accumulated Depreciation & Amortization: increased 23.71% in 2022 and later crashed 34.17% in 2023.
  • Tracing BHC's Accumulated Depreciation & Amortization over 5 years: stood at $1.9 billion in 2022, then crashed by 34.17% to $1.3 billion in 2023, then rose by 0.24% to $1.3 billion in 2024, then dropped by 4.66% to $1.2 billion in 2025, then plummeted by 75.58% to $295.0 million in 2026.
  • Business Quant data shows Accumulated Depreciation & Amortization for BHC at $295.0 million in Q1 2026, $1.2 billion in Q4 2025, and $305.0 million in Q1 2025.